首页> 美国卫生研究院文献>Journal of Neurotrauma >The Effect of Reductive Ventricular Osmotherapy on the Osmolarity of Artificial Cerebrospinal Fluid and the Water Content of Cerebral Tissue Ex Vivo
【2h】

The Effect of Reductive Ventricular Osmotherapy on the Osmolarity of Artificial Cerebrospinal Fluid and the Water Content of Cerebral Tissue Ex Vivo

机译:还原性心室渗透压对人工脑脊液渗透压和离体脑组织水分的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study was to explore a novel treatment involving removal of free water from ventricular cerebrospinal fluid (CSF) for the reduction of cerebra]l edema. The hypothesis is that removal of free water from the CSF will increase the osmolarity of the CSF, which will favor movement of tissue-bound water into the ventricles, where the water can be removed. Reductive ventricular osmotherapy (RVOT) was tested in a flowing solution of artificial CSF (aCSF) with two end-points: (1) the effect of RVOT on osmolarity of the CSF, and (2) the effect of RVOT on water content of ex vivo cerebral tissue. RVOT catheters are made up of membranes permeable only to water vapor. When a sweep gas is drawn through the catheter, free water in the form of water vapor is removed from the solution. With RVOT treatment, aCSF osmolarity increased from a baseline osmolarity of 318.8 ± 0.8 mOsm/L to 339.0 ± 3.3 mOsm/L (mean ± standard deviation) within 2 h. After 10 h of treatment, aCSF osmolarity approached an asymptote at 344.0 ± 4.2 mOsm/L, which was significantly greater than control aCSF osmolarity (p <<0.001 by t-test, n = 8). Water content at the end of 6 h of circulating aCSF exposure was 6.4 ± 0.9 g H2O (g dry wt)−1 in controls, compared to 6.1 ± 0.7 g H2O (g dry wt) after 6 h of RVOT treatment of aCSF (p = 0.02, n = 24). The results support the potential of RVOT as a treatment for cerebral edema and intracranial hypertension.
机译:这项研究的目的是探索一种新的治疗方法,该方法包括从心室脑脊髓液(CSF)中去除游离水,以减轻脑水肿。假设是从脑脊液中除去游离水将增加脑脊液的渗透压,这将有利于组织结合的水向心室运动,在那里可以除去水。在人工脑脊液(aCSF)的流动溶液中测试了还原性心室渗透疗法(RVOT),其具有两个终点:(1)RVOT对脑脊液渗透压的影响;(2)RVOT对脑脊液中水分的影响体内脑组织。 RVOT导管由仅可透过水蒸气的膜组成。当通过导管抽取吹扫气体时,水蒸气形式的自由水会从溶液中去除。在RVOT治疗下,aCSF渗透压在2µh内从基线渗透压(318.8±0.8)mOsm / L增加到339.0±±3.3 mOsm / L(标准差)。在治疗10小时后,aCSF渗透压接近渐近线,为344.0±±4.2 mOsm / L,显着大于对照aCSF渗透压(通过t检验,p 0.001,n == 8)。与对照组相比,在暴露于aCSF的6小时后,水分含量为6.4±±0.9 g H2O(g干重) -1 ,而6.1±0.7μgH2O(g干重)在RVOT治疗aCSF 6小时后(p = 0.02,n = 24)。结果支持RVOT在治疗脑水肿和颅内高压方面的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号